Corrective Phases R...
Health Care: Drugs
ARYx Therapeutics Inc. (ARYX: OTC)
$0.01 0.00 | 0.00%
06/04/12 - 10:53 AM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| ARYX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 15.80 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -83.03 | -96.79 | -99.59 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -100.00 | -1.00 | 0.00 |
| Net Income | 0.21 | 0.00 | |
| EPS | -0.95 | 0.00 |
Earnings for ARYX:
| EBITDA | -29.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (12/10) | Qtr (03/11) | FY (12/10) | FY (12/11) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Number of Analysts | 0 | 0 | 0 | 0 |
| High Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Low Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Prior Year | $-0.21 | $-0.18 | $-1.21 | $n.a. |
| Growth Rate (Year over Year) | n.a.% | n.a.% | n.a.% | n.a.% |
Portfolios with ARYX
- Portfolio NameUser Type
- Contributor5 Drug Stock Losers of 2010
- ContributorEarly Volume Plays: Oct. 29
- UserJonky5 Portfolio 1
Latest ARYX Headlines from TheStreet
- 5 Drug Stock Losers of 2010 12.06.10 | 07:12 am
- Biotech Stock Mailbag: BioSante Pharma 02.26.10 | 07:02 am
- Revlon, Micromet: Early Volume Plays 10.29.09 | 09:10 am
- Biotech ARYx Therapeutics Reports Smaller 2Q Loss 08.13.09 | 02:08 pm
- Last Minute Sprint Overcomes Sellers 07.08.09 | 04:07 pm
- Stock Wrap: The Real Story, July 8
07.08.09 | 04:07 pm - Aryx Keeps Biotech Investors Humble 07.08.09 | 12:07 pm
- Stock Search: Bank of American, Citigroup 06.12.09 | 12:06 pm
- Biotech Calendar: Key Clinical Trial Dates 06.10.09 | 11:06 am
- Aryx Therapeutics 1Q Loss Widens On Revenue Drop 05.14.09 | 11:05 am
Press Releases for ARYX
- ARYx Therapeutics Informed Of Additional Delay By FDA And Begins Wind-Down Of Operations - Business Wire 03.09.11 | 05:03 pm
- ARYx Therapeutics Clarifies Current Status Of Operations - Business Wire 12.23.10 | 08:12 pm
- ARYx Therapeutics To Transfer To The NASDAQ Capital Market - Business Wire 12.21.10 | 06:12 am
- ARYx Therapeutics Provides Update On Company Status - Business Wire 12.15.10 | 08:12 pm
- ARYx Therapeutics Reports Third Quarter Results - Business Wire 11.15.10 | 06:11 am
- ARYx Therapeutics Receives NASDAQ Notice Of Non-Compliance - Business Wire 10.08.10 | 08:10 pm
- ARYx Therapeutics Secures Interim Financing - Business Wire 08.16.10 | 07:08 am
- ARYx Announces Resignation Of Peter G. Milner, President Research And Development - Business Wire 06.02.10 | 08:06 pm
- ARYx Reports First Quarter 2010 Results Of Operations - Business Wire 05.13.10 | 07:05 am
- ARYx Therapeutics Schedules First Quarter 2010 Results Conference Call - Business Wire 05.05.10 | 07:05 am
Partner Headlines for ARYX
- UPDATE 1-Aryx looking for funds to stay afloat beyond Dec 31 - Reuters 12.21.10 | 08:12 am
- China Analyst: 10 Pharma Stocks With Highest Growth Potential - Seeking Alpha 10.08.10 | 06:10 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Aspen / Sigma Lead a Busy Week of Biotech Deals - Seeking Alpha 08.22.10 | 09:08 am
- Best and Worst Performing Russell 3,000 Stocks Year to Date - SeekingAlpha.com 03.26.10 | 11:03 am
- UPDATE 1-ARYx exploring options after licensing talks end - Reuters 02.18.10 | 08:02 pm
